The cry of “atoms, not bits!” — a phrase capturing Silicon Valley’s growing obsession with physical manufacturing over digital products — reached a fever pitch last week with word that Jeff Bezos is ...
Nvidia has a structured data enablement strategy. Nvidia provides libaries, software and hardware to index and search data faster. The Indexing and retrievals are way faster 10-40X faster in most ...
For the past decade, enterprises have equated data accumulation with progress. Organizations invested heavily in lakes, warehouses and pipelines, assuming that more data would naturally lead to better ...
Nigel Farage, leader of the Reform UK party, invested 215,000 pounds ($286,000) in Stack BTC (STAK), a U.K.-listed bitcoin BTC $79,020.41 treasury company, in a fundraising round that also involved ...
Members of the Danville-Pittsylvania Regional Industrial Facility Authority unanimously voted Monday to approve an agreement to sell property at the Southern Virginia Megasite at Berry Hill to SAC III ...
Attackers jailbroke Anthropic’s Claude and ran it against multiple Mexican government agencies for approximately a month. They stole 150 GB of data from Mexico’s federal tax authority, the national ...
Enterprise Strategy Group (ESG), now part of Omdia, released a technical validation report confirming that the Huawei DCS Full-Stack Data Center Solution (Huawei DCS solution) fulfills the data center ...
Companies in most industries are investing heavily in artificial intelligence: 88% of companies reporting regular AI use. Yet many leaders report familiar frustrations. AI adoption stalls. Performance ...
TDWI research shows that architecture modernization is a top priority to help organizations keep pace with increasing demand for data—from AI mandates to the expansion of self-service BI and analytics ...
SoftBank plans to deploy “Infrinia AI Cloud OS” initially within its own GPU cloud services. Furthermore, the Infrinia Team aims to expand deployment to overseas data centers and cloud environments ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results